Insider Trading April 16, 2026 06:25 PM

Clearwater Analytics CFO Disposes $450K in Stock as Buyout Looms

James S. Cox exercises options and sells shares while the company trades near its 52-week high amid acquisition activity and analyst downgrades

By Caleb Monroe CWAN
Clearwater Analytics CFO Disposes $450K in Stock as Buyout Looms
CWAN

Clearwater Analytics Holdings Inc CFO James S. Cox sold 18,600 Class A shares on April 15, 2026, realizing roughly $450,118 as the stock traded near a 52-week high. The Form 4 filing also shows Cox exercised options to acquire 36,968 shares at $4.40 and that a portion of shares were sold to cover tax obligations. The transactions occurred against a backdrop of buyout news, analyst downgrades and a new institutional client win for the company.

Key Points

  • CFO James S. Cox sold 18,600 Class A shares on April 15, 2026, for about $450,118, with sale prices between $24.06 and $24.0718.
  • Cox exercised options for 36,968 shares at $4.40 (totaling $162,659) and disposed of 23,268 shares to cover taxes, yielding $560,061; he now directly owns 480,419 shares.
  • Company developments include a pending acquisition by a Permira- and Warburg Pincus-led investor group, analyst downgrades with $24.55 price targets from UBS and Morgan Stanley, and a commercial mandate from Generali Deutschland AG to manage 0 billion in unit-linked life insurance assets.

Transaction details

Clearwater Analytics Holdings Inc (NYSE:CWAN) reported that its Chief Financial Officer, James S. Cox, sold 18,600 shares of Class A Common Stock on April 15, 2026, generating approximately $450,118 in proceeds. The sales were executed at prices between $24.06 and $24.0718, per the Form 4 filing with the Securities and Exchange Commission.

In the same filing, Cox is recorded as having exercised stock options to acquire 36,968 shares of Class A Common Stock at an exercise price of $4.40, representing a total exercise cost of $162,659. The filing also indicates that 23,268 shares were disposed of to meet tax obligations, producing proceeds of $560,061, with disposal prices ranging from $24.06 to $24.0716.

After these movements, Cox directly holds 480,419 shares of Clearwater Analytics Holdings, Inc. The reported sale was carried out under a Rule 10b5-1 trading plan.


Market context

The timing of Cox's transactions coincided with Clearwater Analytics trading near its 52-week high of $25.07. The stock has climbed about 33% over the past six months.

InvestingPro analysis cited in the filing notes that the $7.1 billion company appears overvalued relative to its Fair Value. The notice mentions that investors can access Pro Research Reports and further analysis on CWAN and other US equities.


Company results and strategic developments

Clearwater Analytics recently reported fourth-quarter results that modestly exceeded forecasts from D.A. Davidson and the consensus. The company did not provide financial guidance for 2026, citing an impending buyout as the reason for withholding forward-looking guidance.

Clearwater has entered into an agreement to be acquired by an investor group led by Permira and Warburg Pincus, with support from Francisco Partners and Temasek. The acquisition process and related disclosures have prompted several analyst reactions and adjustments to ratings.

UBS downgraded Clearwater Analytics from Buy to Neutral and set a price target of $24.55. Morgan Stanley moved its rating from Overweight to Equalweight after the go-shop period for the acquisition expired, also setting a $24.55 price target. RBC Capital downgraded the company to Sector Perform from Outperform, citing the merger proxy statement as a factor.


Commercial win

Separately, the filing notes a client selection: Generali Deutschland AG has chosen Clearwater Analytics to manage its approximately 0 billion unit-linked fund life insurance business. The strategic arrangement is intended to streamline portfolio management and related processes across four of Generali's subsidiaries.


What the filings show and what remains unchanged

The regulatory disclosures provide a clear ledger of the CFO's exercised options, share sales, and tax-related dispositions. They also reaffirm the executive's remaining direct ownership stake of 480,419 shares. Beyond those disclosed transactions and the details of the pending acquisition and client win, the company has declined to issue 2026 guidance due to the buyout process.

All price points, share counts, and transaction dates referenced above are taken from the Form 4 filing and company announcements.

Risks

  • Valuation risk: InvestingPro analysis indicates the $7.1 billion company is overvalued relative to its Fair Value, which could impact investor expectations and market pricing.
  • Guidance uncertainty: Clearwater did not provide financial guidance for 2026 because of the pending buyout, leaving projections and near-term planning less transparent for investors and market participants.
  • Analyst skepticism: Multiple brokers downgraded the stock following acquisition-related disclosures and the expiration of the go-shop period, which introduces additional market uncertainty for the shares.

More from Insider Trading

Klaviyo Co-CEO Sells $3.4M in Shares, Converts Stock Amid Buyback and Product Moves Apr 16, 2026 Insider Sale: 10% Stakeholder Disposes $140K of Rocky Mountain Chocolate Factory Stock Apr 16, 2026 Guardant Health Director Sells 116 Shares; Exercises 250 RSUs Apr 16, 2026 Slide Insurance CEO Disposes $3.4M in Stock; Shares Sold Under Pre-Planned 10b5-1 Program Apr 16, 2026 Slide Insurance COO Shannon Lucas Sells $340K in Stock as Company Reports Strong Q4 Apr 16, 2026